US News

Regeneron's Antibody Drug Cuts Risk of Death in Some Covid-19 Patients

Trial results for REGEN-COV buoy hopes that doctors could soon have a new way to tackle severe hospital cases.

Jump To The Original Source

Facebook Comments

Check Also

Three Sure-fire Ways to Lose Money Investing in SPACs

On its face, the special purpose acquisition company, ...

Archives